|
DCTN2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.446000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.514450E-01 |
| Normal-vs-Stage2 |
1.401830E-02 |
| Normal-vs-Stage3 |
9.805600E-01 |
| Normal-vs-Stage4 |
2.790800E-01 |
| Stage1-vs-Stage2 |
8.165800E-02 |
| Stage1-vs-Stage3 |
1.667790E-01 |
| Stage1-vs-Stage4 |
1.612320E-02 |
| Stage2-vs-Stage3 |
7.981500E-03 |
| Stage2-vs-Stage4 |
1.781740E-03 |
| Stage3-vs-Stage4 |
2.735800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.384200E-01 |
| Normal-vs-AfricanAmerican |
6.508200E-01 |
| Normal-vs-Asian |
1.808250E-01 |
| Caucasian-vs-AfricanAmerican |
9.168200E-01 |
| Caucasian-vs-Asian |
5.059800E-01 |
| AfricanAmerican-vs-Asian |
5.672800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.538580E-01 |
| Normal-vs-Female |
3.641200E-01 |
| Male-vs-Female |
3.908800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.962830E-01 |
| Normal-vs-Age(41-60Yrs) |
3.875000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.721000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.280200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.632800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.135000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.101600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.814400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.936000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.635000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.874000E-02 |
| Classical-VS-Follicular |
1.578840E-01 |
| Classical-VS-Other |
9.133400E-01 |
| Classical-VS-Normal |
2.749000E-01 |
| Tall-VS-Follicular |
1.178290E-02 |
| Tall-VS-Other |
4.991000E-01 |
| Tall-VS-Normal |
2.988600E-01 |
| Follicular-VS-Other |
7.193600E-01 |
| Follicular-VS-Normal |
5.385600E-02 |
| Other-VS-Normal |
7.404600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.058810E-01 |
| Normal-vs-N1 |
3.172000E-02 |
| N0-vs-N1 |
6.769300E-04 |
|
|
